Market closedNon-fractional
Sophia Genetics/SOPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Sophia Genetics
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Ticker
SOPH
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Technology
Headquarters
Rolle, Switzerland
Employees
430
Website
www.sophiagenetics.com
Sophia Genetics Metrics
BasicAdvanced
$303M
Market cap
-
P/E ratio
-$1.12
EPS
1.12
Beta
-
Dividend rate
Price and volume
Market cap
$303M
Beta
1.12
Financial strength
Current ratio
4.144
Quick ratio
3.796
Long term debt to equity
11.146
Total debt to equity
13.19
Interest coverage (TTM)
-126.30%
Management effectiveness
Return on assets (TTM)
-22.52%
Return on equity (TTM)
-46.03%
Valuation
Price to revenue (TTM)
4.69
Price to book
2.3
Price to tangible book (TTM)
2.87
Price to free cash flow (TTM)
-5.274
Growth
Revenue change (TTM)
26.68%
Earnings per share change (TTM)
-11.77%
3-year revenue growth (CAGR)
29.01%
3-year earnings per share growth (CAGR)
6.61%
What the Analysts think about Sophia Genetics
Analyst Ratings
Majority rating from 4 analysts.
Sophia Genetics Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$16M
-7.65%
Net income
-$14M
-42.92%
Profit margin
-87.26%
-38.19%
Sophia Genetics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.33
-$0.21
-$0.37
-$0.21
-
Expected
-$0.31
-$0.32
-$0.27
-$0.27
-$0.27
Surprise
7.70%
-35.05%
37.04%
-23.17%
-
Sophia Genetics News
AllArticlesVideos
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
PRNewsWire·2 days ago
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
PRNewsWire·3 days ago
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024
PRNewsWire·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sophia Genetics stock?
Sophia Genetics (SOPH) has a market cap of $303M as of July 27, 2024.
What is the P/E ratio for Sophia Genetics stock?
The price to earnings (P/E) ratio for Sophia Genetics (SOPH) stock is 0 as of July 27, 2024.
Does Sophia Genetics stock pay dividends?
No, Sophia Genetics (SOPH) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Sophia Genetics dividend payment date?
Sophia Genetics (SOPH) stock does not pay dividends to its shareholders.
What is the beta indicator for Sophia Genetics?
Sophia Genetics (SOPH) has a beta rating of 1.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Sophia Genetics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.